U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval (Q33364668)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval |
scientific article |
Statements
1 reference
U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval (English)
1 reference
Martin H Cohen
1 reference
John R Johnson
1 reference
Richard Pazdur
1 reference
1 January 2005
1 reference
1 reference
11
1 reference
12-19
1 reference
Identifiers
1 reference
1 reference